Eisai Invests in Groundbreaking South African Health Tech Startup RecoMed
TLDR: Eisai, a Japanese pharmaceutical company, made a strategic investment in RecoMed, a South African health tech venture. The investment will support RecoMed’s digital services for breast cancer patients in South Africa.